Did the NIH Quietly Approve Ivermectin for EUA to Treat COVID-19?

Did the NIH Quietly Approve Ivermectin for EUA to Treat COVID-19?


The censorship campaign against Ivermectin is the most heinous crime in modern medical history.

Despite Ivermectin’s success treating COVID-19 in countries like India and Japan, U.S. public health agencies refuse to recommend it.

At least, they won’t publicly state its potential benefits.

Trending: Dr. Stella Immanuel: “The Whole Pandemic Was A TROJAN HORSE For Vaccines – Fauci Is Epitome Of Evil.”

All the American public gets is comments calling this Nobel Prize winning medication “horse dewormer.”

You are not a horse. You are not a cow. Seriously, y'all. Stop it. https://t.co/TWb75xYEY4

— U.S. FDA (@US_FDA) August 21, 2021

But it’s not difficult to figure out why our medical overlords and mainstream media work around the clock to censor Ivermectin.

Its patent expired in 1996 and is cheap to acquire.

Merck’s Ivermectin patent expired 1996.Cost of 5 day required treatment=$15 but Merck,

Continue reading

You Might Like

 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Thanks for sharing!
Send this to a friend